Skip to main
  1. Stocks
  2. PureCycle Technologies
  3. Forecast
PCT

PureCycle Technologies (PCT) Stock Forecast & Price Target

PureCycle Technologies (PCT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 50%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

PureCycle Technologies is supported by a patented, exclusive dissolution process originally developed by P&G, giving it first-mover advantage in a large polypropylene recycling market and a differentiated path to near-virgin PureFive resin. Although 3Q26 revenue of about $2.3M and 5.2M lbs of resin output came in below expectations, the company showed improving commercial traction with 72 active customer trials, 20 qualified applications, 61 samples shipped, and qualification progress across 67 programs, including L’Oréal caps and P&G products on shelves. Its outlook is further reinforced by $393M of liquidity, the 130M-lb Thailand facility targeted to break ground in 1H27, and NJDEP’s extension of the PCR exemption through 2030, which should support longer-term demand growth.

Bears say

PureCycle Technologies is facing a fundamentally weak setup because its 2Q26 net loss widened sharply to about $(142.2M), far worse than the $64.7M estimate and $50.3M consensus, signaling that commercialization is still not translating into operating leverage. Although liquidity improved to $236.9M and the company raised $432.5M in net proceeds from equity and convertible notes, the need to keep funding a capital-intensive project underscores ongoing cash burn, while FY26 UPR resin production was cut to 39.1M lbs from 62.1M lbs and revenue to $25M from $40M. The New Jersey exemption extension to 2030 may support long-term demand, but the pushout of 15 food-contact programs over the next three years and higher FY26 capex to $61M highlight execution risk, delayed monetization, and additional capital needs.

PureCycle Technologies (PCT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 50% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PureCycle Technologies and is not a guaranteed prediction by Public.com or investment advice.

PureCycle Technologies (PCT) Analyst Forecast & Price Prediction

Get the latest PureCycle Technologies (PCT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in PureCycle Technologies (PCT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PureCycle Technologies (PCT) Forecast

Analysts have given PureCycle Technologies (PCT) a Hold based on their latest research and market trends.

According to 2 analysts, PureCycle Technologies (PCT) has a Hold consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PureCycle Technologies (PCT)


PureCycle Technologies (PCT) Analyst Forecast & Price Prediction

Get the latest PureCycle Technologies (PCT) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in PureCycle Technologies (PCT)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover PCT stock data and trends